BEVNEXXA 400MG INJECTION

BEVNEXXA 400MG INJECTION is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to BEVNEXXA 400MG INJECTION, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

BEVNEXXA 400MG INJECTION is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28days before or after surgery.

All the side effects that are relatively caused by BEVNEXXA 400MG INJECTION occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

BEVNEXXA 400MG INJECTION is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with BEVNEXXA 400MG INJECTION in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

There is no known interaction of BEVNEXXA 400MG INJECTION with other drugs.

It is vital to inform your physician before taking BEVNEXXA 400MG INJECTION if you have the following conditions: * Have conditions involving inflammation in the stomach (ulcer, colitis). * Experience allergic reactions to BEVNEXXA 400MG INJECTION or its ingredients. * Have recently undergone surgery as it is associated with the risk of bleeding. * Have diabetes, hypertension, or heart problems.

Bevacizumab is a molecule/combination used for making BEVNEXXA 400MG INJECTION. It is a monoclonal antibody that works by blocking the blood supply to cancer cells, thereby inhibiting their growth and spread.

BEVNEXXA 400MG INJECTION is used in Oncology to treat a variety of cancers. It works by blocking the blood supply to cancer cells, thereby inhibiting their growth and spread.

BEVNEXXA 400MG INJECTION helps in treating cancer in Oncology by blocking the blood supply to cancer cells. This inhibits the growth and spread of cancer cells, leading to reduced tumor size and slowed cancer progression.